TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumors
Abstract Background Perivascular epithelioid cell tumors (PEComas) rarely appear in the head and neck region. This case report describes two transcription factor E3 (TFE3)-rearranged PEComa cases, consisting of one in the orbit and one in the nasal cavity. Case presentation Both cases demonstrated s...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Diagnostic Pathology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13000-025-01602-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832595080228110336 |
---|---|
author | Yuka Takahashi Akihiko Yoshida Seiichi Yoshimoto Shigenobu Suzuki Satsuki Kishikawa Ayaka Mitsui Eijitsu Ryo Yuki Kojima Kan Yonemori Yasushi Yatabe Taisuke Mori |
author_facet | Yuka Takahashi Akihiko Yoshida Seiichi Yoshimoto Shigenobu Suzuki Satsuki Kishikawa Ayaka Mitsui Eijitsu Ryo Yuki Kojima Kan Yonemori Yasushi Yatabe Taisuke Mori |
author_sort | Yuka Takahashi |
collection | DOAJ |
description | Abstract Background Perivascular epithelioid cell tumors (PEComas) rarely appear in the head and neck region. This case report describes two transcription factor E3 (TFE3)-rearranged PEComa cases, consisting of one in the orbit and one in the nasal cavity. Case presentation Both cases demonstrated sheet-like or focal nested architecture and comprised epithelioid cells with abundant clear to eosinophilic cytoplasm and vascular stroma. The first case exhibited partial pleomorphism, a small necrosis area, and slightly increased mitosis and was classified as malignant. The second case demonstrated mild atypia and no mitosis or necrosis and was categorized as benign. The nasal tumor was initially considered a TFE3-rearranged renal cell carcinoma metastasis. However, a subsequent renal tumor biopsy revealed angiomyolipoma. The RNA sequence revealed ZC3H4::TFE3 and PRCC::TFE3 fusions in the first and second cases, respectively. Conclusion The fusion partner gene ZC3H4 is uncommon, and this is the third reported PEComa case. The fusion partner gene PRCC is often reported in TFE3-rearranged renal cell carcinoma, and this PEComa case is the second reported in the head and neck region. The initially reported cases with the fusion partner genes ZC3H4 and PRCC were categorized as malignant. These cases were discussed with a literature review. |
format | Article |
id | doaj-art-e5f6e485d91d47f69a9b83da635fb8cb |
institution | Kabale University |
issn | 1746-1596 |
language | English |
publishDate | 2025-01-01 |
publisher | BMC |
record_format | Article |
series | Diagnostic Pathology |
spelling | doaj-art-e5f6e485d91d47f69a9b83da635fb8cb2025-01-19T12:07:50ZengBMCDiagnostic Pathology1746-15962025-01-0120111010.1186/s13000-025-01602-9TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumorsYuka Takahashi0Akihiko Yoshida1Seiichi Yoshimoto2Shigenobu Suzuki3Satsuki Kishikawa4Ayaka Mitsui5Eijitsu Ryo6Yuki Kojima7Kan Yonemori8Yasushi Yatabe9Taisuke Mori10Department of Diagnostic Pathology, National Cancer Center HospitalDepartment of Diagnostic Pathology, National Cancer Center HospitalDepartment of Head and Neck Surgery, National Cancer Center HospitalDepartment of Ophthalmic Oncology, National Cancer Center HospitalDepartment of Diagnostic Pathology, National Cancer Center HospitalDepartment of Diagnostic Pathology, National Cancer Center HospitalDivision of Molecular Pathology, National Cancer Center Research InstituteDepartment of Medical Oncology, National Cancer Center HospitalDepartment of Medical Oncology, National Cancer Center HospitalDepartment of Diagnostic Pathology, National Cancer Center HospitalDepartment of Diagnostic Pathology, National Cancer Center HospitalAbstract Background Perivascular epithelioid cell tumors (PEComas) rarely appear in the head and neck region. This case report describes two transcription factor E3 (TFE3)-rearranged PEComa cases, consisting of one in the orbit and one in the nasal cavity. Case presentation Both cases demonstrated sheet-like or focal nested architecture and comprised epithelioid cells with abundant clear to eosinophilic cytoplasm and vascular stroma. The first case exhibited partial pleomorphism, a small necrosis area, and slightly increased mitosis and was classified as malignant. The second case demonstrated mild atypia and no mitosis or necrosis and was categorized as benign. The nasal tumor was initially considered a TFE3-rearranged renal cell carcinoma metastasis. However, a subsequent renal tumor biopsy revealed angiomyolipoma. The RNA sequence revealed ZC3H4::TFE3 and PRCC::TFE3 fusions in the first and second cases, respectively. Conclusion The fusion partner gene ZC3H4 is uncommon, and this is the third reported PEComa case. The fusion partner gene PRCC is often reported in TFE3-rearranged renal cell carcinoma, and this PEComa case is the second reported in the head and neck region. The initially reported cases with the fusion partner genes ZC3H4 and PRCC were categorized as malignant. These cases were discussed with a literature review.https://doi.org/10.1186/s13000-025-01602-9Perivascular epithelioid cell tumorTranscription factor E3Head and neckZC3H4PRCC |
spellingShingle | Yuka Takahashi Akihiko Yoshida Seiichi Yoshimoto Shigenobu Suzuki Satsuki Kishikawa Ayaka Mitsui Eijitsu Ryo Yuki Kojima Kan Yonemori Yasushi Yatabe Taisuke Mori TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumors Diagnostic Pathology Perivascular epithelioid cell tumor Transcription factor E3 Head and neck ZC3H4 PRCC |
title | TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumors |
title_full | TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumors |
title_fullStr | TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumors |
title_full_unstemmed | TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumors |
title_short | TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumors |
title_sort | tfe3 rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners clues to the differential diagnosis between benign and malignant tumors |
topic | Perivascular epithelioid cell tumor Transcription factor E3 Head and neck ZC3H4 PRCC |
url | https://doi.org/10.1186/s13000-025-01602-9 |
work_keys_str_mv | AT yukatakahashi tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors AT akihikoyoshida tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors AT seiichiyoshimoto tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors AT shigenobusuzuki tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors AT satsukikishikawa tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors AT ayakamitsui tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors AT eijitsuryo tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors AT yukikojima tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors AT kanyonemori tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors AT yasushiyatabe tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors AT taisukemori tfe3rearrangedperivascularepithelioidcelltumorsoftheheadandneckwithrarefusionpartnerscluestothedifferentialdiagnosisbetweenbenignandmalignanttumors |